U.S. to cover advanced genomic testing for Medicare cancer patients

(Reuters) - The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.